Professor Zuckerman told Michael Gillard that he had visited Immuno in Vienna, and thought it was a poor facility, which lacked medical back-up and had "dubious sources of plasma".
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Professor Arie Zuckerman